Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | growth factor receptor-bound protein 2 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Leishmania major | hypothetical protein, conserved | growth factor receptor-bound protein 2 | 217 aa | 200 aa | 23.5 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | DNA polymerase I alpha catalytic subunit, putative | 0.0026 | 0.0026 | 0.0026 |
Toxoplasma gondii | hypothetical protein | 0.0053 | 0.0386 | 1 |
Trypanosoma cruzi | DNA repair and recombination helicase protein PIF7, putative | 0.0775 | 1 | 1 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0156 | 0.1752 | 0.1752 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0173 | 0.1986 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.009 | 0.088 | 0.088 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0056 | 0.043 | 0.043 |
Trypanosoma brucei | retrotransposon hot spot protein 4 (RHS4), interrupted | 0.0026 | 0.0027 | 0.0027 |
Trypanosoma brucei | DNA polymerase beta thumb, putative | 0.0046 | 0.0295 | 0.0295 |
Trypanosoma cruzi | DNA polymerase beta thumb, putative | 0.0046 | 0.0295 | 0.0295 |
Toxoplasma gondii | DNA polymerase (pol2) superfamily protein | 0.0048 | 0.0323 | 0.8359 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0046 | 0.0295 | 0.0295 |
Entamoeba histolytica | hypothetical protein, conserved | 0.0775 | 1 | 0.5 |
Giardia lamblia | DNA polymerase alpha subunit A | 0.005 | 0.0351 | 0.0351 |
Echinococcus granulosus | DNA polymerase alpha catalytic subunit | 0.0059 | 0.0472 | 0.0472 |
Leishmania major | mitochondrial DNA polymerase beta | 0.0329 | 0.4058 | 0.4058 |
Trypanosoma brucei | RNA helicase, putative | 0.009 | 0.088 | 0.088 |
Onchocerca volvulus | DNA polymerase alpha catalytic subunit homolog | 0.0082 | 0.0769 | 1 |
Trypanosoma cruzi | DNA polymerase beta thumb, putative | 0.0046 | 0.0295 | 0.0295 |
Echinococcus multilocularis | hypothetical protein | 0.0107 | 0.111 | 0.111 |
Leishmania major | PIF1 helicase-like protein, putative,DNA repair and recombination protein, mitochondrial precursor, putative | 0.0775 | 1 | 1 |
Leishmania major | PIF1 helicase-like protein, putative,DNA repair and recombination protein, mitochondrial precursor, putative | 0.0775 | 1 | 1 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0329 | 0.4058 | 0.4058 |
Trypanosoma brucei | ingi protein (ORF1) | 0.0026 | 0.0027 | 0.0027 |
Schistosoma mansoni | DNA polymerase gamma | 0.0107 | 0.111 | 0.111 |
Trypanosoma brucei | mitochondrial DNA polymerase beta | 0.0329 | 0.4058 | 0.4058 |
Trypanosoma brucei | DNA repair and recombination helicase protein PIF7 | 0.0775 | 1 | 1 |
Echinococcus granulosus | DNA polymerase subunit gamma | 0.0107 | 0.111 | 0.111 |
Schistosoma mansoni | growth factor receptor-bound protein | 0.0152 | 0.1704 | 0.1704 |
Loa Loa (eye worm) | hypothetical protein | 0.0107 | 0.111 | 0.3643 |
Giardia lamblia | Rrm3p helicase | 0.0775 | 1 | 1 |
Trypanosoma brucei | ingi protein (ORF1) | 0.0026 | 0.0027 | 0.0027 |
Schistosoma mansoni | growth factor receptor-bound protein | 0.0152 | 0.1704 | 0.1704 |
Trypanosoma brucei | mitochondrial DNA polymerase beta-PAK | 0.0156 | 0.1752 | 0.1752 |
Trypanosoma cruzi | DNA repair and recombination helicase protein PIF7, putative | 0.0775 | 1 | 1 |
Treponema pallidum | ribonuclease H (rnhA) | 0.0024 | 0 | 0.5 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0026 | 0.0027 | 0.0027 |
Schistosoma mansoni | hypothetical protein | 0.0775 | 1 | 1 |
Trichomonas vaginalis | DNA polymerase alpha catalytic subunit, putative | 0.0026 | 0.0026 | 0.0026 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0775 | 1 | 1 |
Brugia malayi | DNA polymerase alpha catalytic subunit | 0.0048 | 0.0323 | 0.1893 |
Schistosoma mansoni | DNA polymerase alpha catalytic subunit | 0.0059 | 0.0472 | 0.0472 |
Wolbachia endosymbiont of Brugia malayi | ribonuclease HI | 0.0024 | 0 | 0.5 |
Loa Loa (eye worm) | sex muscle abnormal protein 5 | 0.0152 | 0.1704 | 1 |
Trichomonas vaginalis | DNA polymerase II, putative | 0.0026 | 0.0026 | 0.0026 |
Echinococcus granulosus | growth factor receptor bound protein 2 | 0.0152 | 0.1704 | 0.1704 |
Echinococcus multilocularis | DNA polymerase alpha catalytic subunit | 0.0059 | 0.0472 | 0.0472 |
Mycobacterium ulcerans | hypothetical protein | 0.0173 | 0.1986 | 0.5 |
Plasmodium vivax | DNA polymerase alpha, putative | 0.0048 | 0.0323 | 0.5 |
Echinococcus multilocularis | growth factor receptor bound protein 2 | 0.0152 | 0.1704 | 0.1704 |
Trypanosoma brucei | DNA repair and recombination helicase protein PIF6 | 0.0775 | 1 | 1 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0329 | 0.4058 | 0.4058 |
Trypanosoma brucei | DNA polymerase alpha catalytic subunit | 0.0026 | 0.0026 | 0.0026 |
Brugia malayi | DNA polymerase I family protein | 0.0107 | 0.111 | 0.6512 |
Trypanosoma cruzi | DNA repair and recombination helicase protein PIF6, putative | 0.0775 | 1 | 1 |
Leishmania major | mitochondrial DNA polymerase beta-PAK, putative | 0.0156 | 0.1752 | 0.1752 |
Entamoeba histolytica | DNA repair and recombination protein, putative | 0.0775 | 1 | 0.5 |
Echinococcus multilocularis | ATP dependent DNA helicase PIF1 | 0.0775 | 1 | 1 |
Brugia malayi | Sex muscle abnormal protein 5 | 0.0152 | 0.1704 | 1 |
Trypanosoma brucei | unspecified product | 0.0026 | 0.0027 | 0.0027 |
Trypanosoma cruzi | DNA polymerase I alpha catalytic subunit, putative | 0.0026 | 0.0026 | 0.0026 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.